Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayman

Showing results (141-150 of 446) with videos related to

Pageof 45
Sort By:
British Journal of Haematology|December 5, 2009
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myelomaShirshendu Sinha, S Vincent Rajkumar, Martha Q Lacy, et al.
Oncology|June 7, 2014
Urinary podocyte excretion and proteinuria in patients treated with antivascular endothelial growth factor therapy for solid tumor malignanciesSuzanne R Hayman, Juan C Calle, Aminah Jatoi, et al.
Leukemia|February 28, 2024
Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-upNadine Abdallah, Thomas E Witzig, Shaji K Kumar, et al.
Bone Marrow Transplantation|July 1, 2008
Impact of early relapse after auto-SCT for multiple myelomaS Kumar, S T Mahmood, M Q Lacy, et al.
Mayo Clinic Proceedings|March 5, 2008
Serum uric acid: novel prognostic factor in primary systemic amyloidosisShaji Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Journal of Virology|January 23, 2023
The Epstein-Barr Virus Glycoprotein BDLF2 Is Essential for Efficient Viral Spread in Stratified EpitheliumJoshua J Walston, Ian R Hayman, Mindy Gore, et al.
Mayo Clinic Proceedings|January 7, 2018
Safety Outcomes for Autologous Stem Cell Transplant in Multiple MyelomaMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Neurology|March 17, 2010
Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosisD Dingli, T S Tan, S K Kumar, et al.
Bone Marrow Transplantation|November 11, 2008
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myelomaM A Gertz, S K Kumar, M Q Lacy, et al.
Bone Marrow Transplantation|August 23, 2016
The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agentsR Chakraborty, E Muchtar, S Kumar, et al.
Pageof 45

Showing results (141-150 of 446) with videos related to

Sort By:
Pageof 45
British Journal of Haematology|December 5, 2009
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myelomaShirshendu Sinha, S Vincent Rajkumar, Martha Q Lacy, et al.
Oncology|June 7, 2014
Urinary podocyte excretion and proteinuria in patients treated with antivascular endothelial growth factor therapy for solid tumor malignanciesSuzanne R Hayman, Juan C Calle, Aminah Jatoi, et al.
Leukemia|February 28, 2024
Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-upNadine Abdallah, Thomas E Witzig, Shaji K Kumar, et al.
Bone Marrow Transplantation|July 1, 2008
Impact of early relapse after auto-SCT for multiple myelomaS Kumar, S T Mahmood, M Q Lacy, et al.
Mayo Clinic Proceedings|March 5, 2008
Serum uric acid: novel prognostic factor in primary systemic amyloidosisShaji Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Journal of Virology|January 23, 2023
The Epstein-Barr Virus Glycoprotein BDLF2 Is Essential for Efficient Viral Spread in Stratified EpitheliumJoshua J Walston, Ian R Hayman, Mindy Gore, et al.
Mayo Clinic Proceedings|January 7, 2018
Safety Outcomes for Autologous Stem Cell Transplant in Multiple MyelomaMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Neurology|March 17, 2010
Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosisD Dingli, T S Tan, S K Kumar, et al.
Bone Marrow Transplantation|November 11, 2008
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myelomaM A Gertz, S K Kumar, M Q Lacy, et al.
Bone Marrow Transplantation|August 23, 2016
The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agentsR Chakraborty, E Muchtar, S Kumar, et al.
Pageof 45